BLNK as an important prognostic indicator for survival in pediatric classic hodgkin lymphoma patients: a single-center retrospective study
Abstract Classic Hodgkin lymphoma (cHL) is a malignant tumor in children. At present, some patients cannot be cured with first-line treatment, and many cured patients die prematurely because of the late toxic effects of treatment. In addition, effective early survival prediction biomarkers are lacki...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer
2025-10-01
|
| Cyfres: | Annals of Hematology |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1007/s00277-025-06697-0 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|